Toshiba releases Xpress/GX CT scanner
Toshiba America Medical Systems has released a new CT scannerthat moves the spiral scanning technology of the company's premiumXpress/SX scanner to a more compact package. Xpress/GX is a one-secondscanner that is 50% smaller and 30% lighter than most
Toshiba America Medical Systems has released a new CT scannerthat moves the spiral scanning technology of the company's premiumXpress/SX scanner to a more compact package. Xpress/GX is a one-secondscanner that is 50% smaller and 30% lighter than most systemson the market, according to the Tustin, CA, vendor.
Toshiba achieved space savings by incorporating the scanner'sx-ray generator into the gantry. The system also uses a new opticaldata transmission technology for transferring data from rotatingx-ray detectors to the display. Xpress/GX can be installed intoa 10 x 20-foot room and weighs just over 4100 pounds.
The scanner employs nearly 900 solid-state detectors, has aspatial resolution of 18 lp/cm and ships standard with a 3.5-million-heat-unit x-ray tube. It can resolve objects as smallas 2.5 mm at 0.25% contrast, and standard image reconstructiontakes five seconds. Xpress/GX will carry a list price of $890,000.
Toshiba's new scanners, including the Xpress/SX, have improvedthe company's CT market-share position this year, according toJohn Ariatti, vice president of marketing. Toshiba estimates itsU.S. market share at just under 10%, several points higher thanits share last year, Ariatti said.
FDA Grants Fast Track Designation to Emerging Agent for Brain PET Imaging
June 11th 2025Currently being evaluated in a phase 2b clinical trial, the 18F-RAD101 PET imaging agent garnered the FDA’s fast track designation for distinguishing between recurrent disease and treatment impact for brain metastases derived from solid tumors.
New PSMA PET Prep Product Now Available in the U.S.
June 11th 2025Offering an extended shelf life, the FDA-approved Gozellix, a preparation kit for gallium-68 (68Ga) gozetotide injection, is indicated for use in PSMA PET imaging of prostate cancer patients with suspected recurrence or metastasis.
